Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Multicenter, Open-label Extension Study of Buccally Administered MHOS/SHP615 in Pediatric Patients With Status Epilepticus (Convulsive) in Community Settings

NCT03336450 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT03336450
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03336450 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Multicenter, Open-label Extension Study of Buccally Administered MHOS/SHP615 in Pediatric Patients With Status Epilepticus (Convulsive) in Community Settings
Lead sponsor
Shire
Phase
Phase 3
Overall status
Completed
Start date
April 23, 2018
Completion date
October 13, 2020
Enrollment
3 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

nervous system diseases